Single-centre trial of 131 patients having trabeculectomy with mitomycin-C: one intraoperative intravitreal bevacizumab injection vs placebo improved surgical success at 36 months (hazard ratio 0.17 complete, 0.07 qualified success); 111 completed follow-up.
RCTn = 131
Landers et al. Intravitreal Bevacizumab Improves Trabeculectomy Survival at 3 Years: Long-term Follow-up from the Bevacizumab in Trabeculectomy Study